Linked Life Data

11403530

Source:http://linkedlifedata.com/resource/pubmed/id/11403530

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2001-6-13
pubmed:abstractText
Successful treatment of narcolepsy requires an accurate diagnosis to exclude patients with other sleep disorders, which have different treatments, and to avoid unnecessary complications of drug treatment. Treatment objectives should be tailored to individual circumstances. Modafinil, amphetamine, methamphetamine, dextroamphetamine, methylphenidate, selegiline, pemoline, tricyclic antidepressants, and fluoxetine are effective treatments for narcolepsy, but the quality of published clinical evidence supporting them varies. Scheduled naps can be beneficial to combat sleepiness, but naps seldom suffice as primary therapy. Regular follow up of patients with narcolepsy is necessary to educate patients and their families, monitor for complications of therapy and emergent of other sleep disorders, and help the patient adapt to the disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0161-8105
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
451-66
pubmed:dateRevised
2009-1-29
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
Practice parameters for the treatment of narcolepsy: an update for 2000.
pubmed:affiliation
VA Greater Los Angeles Healthcare System and UCLA School of Medicine, Sepulveda, CA, USA.
pubmed:publicationType
Journal Article, Guideline, Clinical Trial, Randomized Controlled Trial, Practice Guideline